Digestive Diseases and Sciences

, Volume 44, Issue 12, pp 2516–2522 | Cite as

Type II 11β-Hydroxysteroid Dehydrogenase Expression in Human Colonic Epithelial Cells of Inflammatory Bowel Disease

  • Ken-Ichi Takahashi
  • Kouhei Fukushima
  • Hironobu Sasano
  • Iwao Sasaki
  • Seiki Matsuno
  • Zygmunt S. Krozowski
  • Hiroshi Nagura


Type II 11β-hydroxysteroid dehydrogenaseendows specificity on the mineralocorticoid receptor bymetabolizing cortisol and regulates sodium absorption inrenal and colonic epithelium. Altered expression of this enzyme may be associated with impairedsodium absorption often seen in colonic mucosa ofinflammatory bowel disease. The aim of this study was toinvestigate possible abnormality of11β-hydroxysteroid dehydrogenase protein and mRNA expression ininflammatory bowel disease. In Crohn's disease, thecolonic epithelium showed comparable levels ofimmunoreactivity and mRNA expression to those ofcontrol, except for the decreased immunoreactivity insevere inflamed lesions with deep ulcer. In contrary, alack or decrease of immunoreactivity was relevant inulcerative colitis regardless of the histological degree of inflammation. The mRNA expression wasalso significantly decreased in ulcerative colitis. Thisstudy demonstrates that abnormality of epithelial cellsin ulcerative colitis includes the enzyme that regulates water and sodium absorption,which are physiologically essential.



Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mayer L, Eisenhardt D, Salomon P, Bauer W, Plous R, Piccinini L: Expression of class II molecules on intestinal epithelial cells in humans. Differences between normal and inflammatory bowel disease. Gastroenterology 100:3–12, 1991Google Scholar
  2. 2.
    Gibson P, Rosella O: Inte rleukin 8 secretion by colonic crypt cells in vitro: Response to injury suppressed by butyrate and enhanced in inflammatory bowel disease. Gut 37:536–543, 1995Google Scholar
  3. 3.
    Kusugami K, Fukatsu A, Tanimoto M, Shinoda M, Haruta J, Kuroiwa A, Ina K, Kanayama K, Ando T, Matsuura T, Yamaguchi T, Morise K, Ieda M, Iokawa H, Ishihara A, Sarai S: Elevation ofinterleukin-6 in inflammatory bowel disease is macrophage-and epithelial cell-dependent. Dig Dis Sci 40:949–959, 1995Google Scholar
  4. 4.
    Fukushima K, Fiocchi C: Decreased frequency of mitochondrial DNA deletions in epithelial cells from active ulcerative colitis. Gastroente rology 108:A688, 1995Google Scholar
  5. 5.
    Roediger WEW: The colonic epithelium in ulcerative colitis: An energy-deficiency disease? Lancet 2:712–715, 1980Google Scholar
  6. 6.
    Kameyama J, Narui H, Inui M, Sato T: Energy level in large intestinal mucosa in patients with ulcerative colitis. Tohoku J Exp Med 143:253–254, 1984Google Scholar
  7. 7.
    Das KM, Dasgupta A, Mandal A, Geng X: Autoimmunity to cytoske letal protein tropomyosin. J Immunol 150:2487–2493, 1993Google Scholar
  8. 8.
    Hollander D, Vadheim CM, Brettholz E, Petersen GM, Delahunty T, Rotter JI: Increased perme ability in patients with Crohn's disease and their relatives. Ann Intern Med 105:883–885, 1986Google Scholar
  9. 9.
    Traynor TR, Brown DR, O'Grady SM: Effects ofinflammatory mediators on electrolyte transport across the porcine distal colon epithelium. J Pharmacol Exp Ther 264:61–66, 1993Google Scholar
  10. 10.
    Percy WH, Burton MB, Glaws WR, Rose K, Burakoff R: Pharmacological basis of contractile effects of peptidoleukotriene s on rabbit colonic muscularis mucosae. Am J Physiol 264:G81-G85, 1993Google Scholar
  11. 11.
    Hawker PC, McKey JS, Turnberg LA: Electrolyte transport across colonic mucosa from patients with inflammatory bowel disease. Gastroenterology 79:508–511, 1980Google Scholar
  12. 12.
    Sandle GI, Higgs N, Crowe P, Marsh MN, Venkatesan S, Peters TJ: Cellular basis for defective electrolyte transport in inflamed human colon. Gastroenterology 99:97–105, 1990Google Scholar
  13. 13.
    Levitan R, Ingelfinger FJ: Effect of d-aldosterone on salt and water absorption from the intact human colon. J Clin Invest 44:801–808, 1965Google Scholar
  14. 14.
    Sandle GI, Binder HJ: Corticosteroids and intestinal ion transport. Gastroenterology 93:188–196, 1987Google Scholar
  15. 15.
    Krozowski ZS, Funder JW: Renal mineralocorticoid receptors and hippocampal cortisone-binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci USA 80:6056–6060, 1983Google Scholar
  16. 16.
    Edward CR, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, deKloet ER, Monder C: Localization of 11 betahydroxyste roid dehydrogenase–tissue specific protector of the mineralocorticoid rece ptor. Lancet 2:986–989, 1988Google Scholar
  17. 17.
    Funder JW, Pearce PT, Smith R, Smith AI: Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated. Science 242:583–585, 1988Google Scholar
  18. 18.
    Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS: Cloning and tissue distribution of the human 11 betahydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol 105:R11-R17, 1994Google Scholar
  19. 19.
    Smith RE, Maguire JA, Stein-Oakley AN, Sasano H, Takahashi K, Fukushima K, Krozowski ZS: Localization of 11 beta-hydroxysteroid dehydrogenase type II in human epithelial tissues. J Clin Endocrinol Metabol 81:3244–3248, 1996Google Scholar
  20. 20.
    Hirasawa G, Sasano H, Takahashi K, Fukushima K, Suzuki T, Hiwatashi N, Toyota T, Krozowski ZS, Nagura H: Colocalization of 11 beta-Hydroxysteroid dehydrogenase type II and mineralocorticoid receptor in human epithelia. J Clin Endocrinol Metab 82:3859–3863, 1997Google Scholar
  21. 21.
    Matts SGF: The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med 120:393–407, 1961Google Scholar
  22. 22.
    Kimura M, Masuda T, Hiwatashi N, Toyota T, Nagura H: Changes in neuropeptide-containing nerves in human colonic mucosa with inflammatory bowel disease. Pathol Intern 44:624–634, 1994Google Scholar
  23. 23.
    Youngman KR, Simon PL, West GA, Cominelli F, Rachmile-witz D, Klein JS, fiocchi C: Localization ofintestinal interleukin 1 activity and protein and gene expre ssion to lamina propria cells. Gastroenterology 104:749–758, 1993Google Scholar
  24. 24.
    Ponte P, Ng SY, Engel J, Gunning P, Kedes L: Evolutionary conservation in the untranslated regions of action mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res 12:1687–1696, 1984Google Scholar
  25. 25.
    Fukushima K, Sasaki I, Hasegawa H, Takahashi K, Naito H, Funayama Y, Matsuno S: Sodium butyrate-induced liver-type alkaline phosphatase activity in a small intestinal epithelial cell line, IEC6. Dig Dis Sci 43:1116–1123, 1998Google Scholar
  26. 26.
    Calvo CF, Chavanel G, Senik A: Substance P enhances IL-2 expression in activated human T cells. J Immunol 148:3498–3504, 1992Google Scholar
  27. 27.
    Allan A, Bristol JB, Williamson RCN: Crypt cell production in ulcerative proctocolitis: Differential increments in remission and relapse. Gut 26:999–1003, 1985Google Scholar
  28. 28.
    Eastwood GL, Trier JS: Epithelial cell renewal in cultured rectal biopsies in ulcerative colitis. Gastroenterology 64:383–390, 1973Google Scholar

Copyright information

© Plenum Publishing Corporation 1999

Authors and Affiliations

  • Ken-Ichi Takahashi
  • Kouhei Fukushima
  • Hironobu Sasano
  • Iwao Sasaki
  • Seiki Matsuno
  • Zygmunt S. Krozowski
  • Hiroshi Nagura

There are no affiliations available

Personalised recommendations